ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ACAD on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
170,107,714
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
167,652,719
Holdings value
$3,576,525,165
% of all portfolios
0%
Number of holders
326
Number of buys
180
Number of sells
-137
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11.9% $292,813,929 19,878,746 BlackRock, Inc. 31 Jan 2025
RTW INVESTMENTS, LP 4.2% -20% $152,464,142 -$33,311,249 7,144,524 -18% RTW Investments, LP 30 Sep 2025

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 167,652,719 $3,576,525,165 -$46,292,455 $21.34 326
2025 Q2 169,807,590 $3,663,065,967 -$28,402,837 $21.57 308
2025 Q1 171,490,817 $2,848,881,391 +$139,123,298 $16.61 315
2024 Q4 162,840,883 $2,987,247,881 +$134,856,202 $18.35 292
2024 Q3 155,896,219 $2,398,194,293 -$102,074,875 $15.38 257
2024 Q2 161,184,775 $2,619,212,148 -$8,478,472 $16.25 265
2024 Q1 161,305,797 $2,982,051,495 -$11,656,862 $18.49 266
2023 Q4 159,519,491 $4,994,576,405 +$146,161,056 $31.31 272
2023 Q3 156,109,164 $3,253,545,379 -$82,496,501 $20.84 246
2023 Q2 159,054,444 $3,809,481,545 +$45,597,747 $23.95 232
2023 Q1 158,037,917 $2,974,292,426 +$53,351,193 $18.82 231
2022 Q4 155,962,184 $2,482,889,933 +$28,684,244 $15.92 221
2022 Q3 152,629,101 $2,497,282,084 +$30,373,584 $16.36 213
2022 Q2 150,587,330 $2,121,823,126 +$730,128 $14.09 229
2022 Q1 147,043,761 $3,562,570,671 -$19,931,550 $24.22 254
2021 Q4 148,180,956 $3,457,975,885 +$79,727,176 $23.34 238
2021 Q3 144,785,492 $2,405,101,667 -$85,712,883 $16.61 221
2021 Q2 148,041,851 $3,610,234,111 +$54,424,511 $24.39 238
2021 Q1 145,061,195 $3,742,096,150 -$221,828,762 $25.8 258
2020 Q4 147,844,682 $7,903,754,877 -$103,617,443 $53.46 298
2020 Q3 150,041,187 $6,188,429,775 -$100,187,840 $41.25 262
2020 Q2 152,670,605 $7,396,593,388 -$42,512,386 $48.47 292
2020 Q1 153,864,301 $6,498,311,210 +$189,756,698 $42.25 243
2019 Q4 149,336,660 $6,388,574,478 +$119,463,838 $42.78 271
2019 Q3 146,311,376 $5,266,836,210 +$305,519,803 $35.99 230
2019 Q2 138,214,602 $3,694,065,190 +$147,260,802 $26.73 195
2019 Q1 137,820,078 $3,700,427,361 -$451,990 $26.85 197
2018 Q4 139,179,591 $2,250,311,406 +$303,421,206 $16.17 174
2018 Q3 119,874,855 $2,488,872,088 +$110,894,846 $20.76 179
2018 Q2 116,880,774 $1,784,764,158 -$138,301,487 $15.27 179
2018 Q1 122,155,744 $2,744,894,235 +$37,280,386 $22.47 190
2017 Q4 120,025,542 $3,614,245,070 +$37,065,407 $30.11 208
2017 Q3 117,812,246 $4,438,878,279 -$56,072,336 $37.67 207
2017 Q2 119,784,893 $3,339,520,564 +$82,800,071 $27.89 199
2017 Q1 119,547,665 $4,109,936,889 +$169,511,200 $34.38 215
2016 Q4 121,076,367 $3,491,800,173 +$84,990,989 $28.84 217
2016 Q3 117,841,646 $3,747,670,757 +$216,713,692 $31.81 226
2016 Q2 111,052,551 $3,607,314,539 +$14,491,210 $32.46 223
2016 Q1 110,397,760 $3,086,115,226 +$351,841,425 $27.96 210
2015 Q4 97,471,495 $3,474,862,840 -$45,955,147 $35.65 209
2015 Q3 98,550,415 $3,258,991,567 +$13,497,283 $33.07 184
2015 Q2 98,249,994 $4,115,830,564 +$65,989,817 $41.88 187
2015 Q1 97,313,733 $3,171,615,843 +$38,284,508 $32.59 193
2014 Q4 96,269,604 $3,056,562,395 +$57,829,247 $31.75 182
2014 Q3 94,226,006 $2,333,141,119 -$12,371,945 $24.76 162
2014 Q2 95,058,715 $2,147,349,372 +$59,674,967 $22.59 160
2014 Q1 90,910,051 $2,211,056,887 +$189,059,322 $24.33 164